{"product_id":"public-policy-in-alsmnd-care-an-international-perspective-9789811558429","title":"Public Policy in ALS\/MND Care: An International Perspective","description":"\u003cp\u003e\u003c\/p\u003e\u003cblockquote\u003e\n\u003cbr\u003eThis book explores the public policy and political\/ethical dimensions of ALS\/MND across countries, advocating for a multidisciplinary and international approach. It addresses funding, payment, long-term services, public health, access to technologies, workforce, palliative care, advance directives, and assisted suicide. \u003c\/blockquote\u003e\u003cp\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e: Paperback \/ softback\u003cbr\u003e\u003cstrong\u003eLength\u003c\/strong\u003e: 347 pages\u003cbr\u003e\u003cstrong\u003ePublication date\u003c\/strong\u003e: 29 November 2021\u003cbr\u003e\u003cstrong\u003ePublisher\u003c\/strong\u003e: Springer Verlag, Singapore\u003cbr\u003e\u003c\/p\u003e \u003cp\u003e\u003cbr\u003eThis book delves into the intricate interplay between public policy and the political\/ethical dimensions of ALS\/MND,spanning a diverse range of countries. It compellingly advocates for a multidisciplinary and international approach to address these pressing issues. Within its pages, policy concerns such as the adequacy of funding for research and care, the complexities of payment policies and regulatory functions of public and private insurers, the provision of long-term services and caregiver support, public health and prevention efforts, access to genetic testing and assisted technologies, ensuring a skilled and compassionate workforce, particularly for hands-on caregivers, and the complex challenges of delivering palliative and hospice care to ALS\/MND patients, as well as advance directives and assisted suicide, which confront policy makers across all political jurisdictions, are explored in depth.\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eIntroduction:\u003c\/strong\u003e\u003cbr\u003eThe study of ALS\/MND encompasses a wide range of factors, including public policy, political\/ethical dimensions, and multidisciplinary approaches. This book aims to shed light on these critical aspects and advocate for a comprehensive and international perspective.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003ePolicy Issues:\u003c\/strong\u003e\u003cbr\u003eAdequacy of Funding for Research and Care:\u003cbr\u003eThe funding of research and care for ALS\/MND is a crucial policy concern. Insufficient funding can hinder progress in understanding the disease, developing effective treatments, and providing support to patients and caregivers. This requires a commitment from governments, private organizations, and international agencies to allocate resources to ALS\/MND research and care.\u003cbr\u003e\u003cbr\u003ePayment Policy and Regulatory Functions of Public and Private Insurers:\u003cbr\u003ePayment policies and regulatory functions of public and private insurers play a significant role in determining access to healthcare services for ALS\/MND patients. Ensuring fair and adequate coverage, managing costs, and providing appropriate incentives for providers are essential to ensure that patients receive the care they need.\u003cbr\u003e\u003cbr\u003eLong-Term Services and Caregiver Support:\u003cbr\u003e ALS\/MND is a progressive disease that requires long-term services and caregiver support. Providing comprehensive support to patients and caregivers, including respite care, home care, and hospice care, is crucial to improve their quality of life and ensure their well-being.\u003cbr\u003e\u003cbr\u003ePublic Health and Prevention Efforts:\u003cbr\u003ePublic health and prevention efforts are crucial in reducing the impact of ALS\/MND. Educating the public about the disease, promoting early diagnosis, and developing effective prevention strategies can help reduce the burden of the disease and improve patient outcomes.\u003cbr\u003e\u003cbr\u003eAccess to Genetic Testing and Assisted Technologies:\u003cbr\u003eAccess to genetic testing and assisted technologies can help improve the understanding of ALS\/MND and enable personalized treatment approaches. Providing access to these technologies can improve patient outcomes and quality of life.\u003cbr\u003e\u003cbr\u003eEnsuring a Competent and Adequate Workforce:\u003cbr\u003e ALS\/MND requires a skilled and compassionate workforce, particularly for hands-on caregivers. Ensuring that healthcare professionals have the necessary training and support to provide quality care to ALS\/MND patients is essential.\u003cbr\u003e\u003cbr\u003eChallenges of Providing Palliative and Hospice Care:\u003cbr\u003eProviding palliative and hospice care to ALS\/MND patients is a complex challenge. It involves managing pain and symptoms, providing emotional support, and addressing the spiritual and social needs of patients and caregivers. Ensuring that palliative and hospice care is accessible, affordable, and integrated into the healthcare system is essential.\u003cbr\u003e\u003cbr\u003eAdvance Directives and Assisted Suicide:\u003cbr\u003eAdvance directives and assisted suicide are challenging issues that face policy makers in all political jurisdictions. These issues involve the rights of patients to make decisions about their end-of-life care and the ethical considerations surrounding assisted suicide. Policy makers need to balance the interests of patients and caregivers, while also ensuring that these decisions are made in a respectful and compassionate manner.\u003cbr\u003e\u003cbr\u003eConclusion:\u003cbr\u003eThe study of ALS\/MND requires a multidisciplinary and international approach. By addressing policy issues such as funding, payment policies, caregiver support, public health and prevention efforts, access to genetic testing and assisted technologies, ensuring a competent and adequate workforce, and addressing palliative and hospice care, we can improve the lives of ALS\/MND patients and their caregivers. It is essential to advocate for policies that prioritize the needs of ALS\/MND patients and their caregivers and to work towards a future where ALS\/MND is no longer a burden to individuals and society.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eWeight\u003c\/strong\u003e: 498g\u003cbr\u003e\u003cstrong\u003eDimension\u003c\/strong\u003e: 210 x 148 (mm)\u003cbr\u003e\u003cstrong\u003eISBN-13\u003c\/strong\u003e: 9789811558429\u003cbr\u003e \u003cstrong\u003eEdition number\u003c\/strong\u003e: 1st ed. 2021\u003c\/p\u003e","brand":"Shulph Ink","offers":[{"title":"Paperback \/ softback","offer_id":44103218004218,"sku":"9789811558429","price":91.62,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/4297\/2845\/products\/1646373880627_book.jpg?v=1646983500","url":"https:\/\/shulphink.com\/products\/public-policy-in-alsmnd-care-an-international-perspective-9789811558429","provider":"Shulph Ink","version":"1.0","type":"link"}